… . (BIIB) on Friday announced a license agreement with Vanqua Bio granting … : Eli Lilly To Acquire Adverum Biotechnologies For updates and corrections, email …

Biogen is putting more than $1 billion on the table for rights to an experimental, immune system-regulating drug that has yet to enter human testing. Through a deal announced Friday, Biogen will pay privately held Vanqua Bio $70 million up front for …

… -dollar licensing deals involving Chinese biotechs, Takeda …   At Fierce Biotech Week earlier this … licensing of drug candidates from China. “We can have TikTok,” the biotech … Biotech. Sacituzumab tirumotecan (sac-TMT), developed by China’s Kelun and licensed …

… Science, a scrappy Italian biotech powerhouse listed on Nasdaq, just … Rollercoaster Look, trading these biotech names is like riding the … markets, especially small-cap biotechs like this one (market … ve got a recipe for licensing deals, combo therapies with …

… them.Innsbruck-based company Angios Biotech specialises in developing cell-based … discovery or Myllia Biotechnology at BIO-Europe. Myllia Biotechnology will be presenting … by Siemens Healthineers and exclusively licensed to Aitiologic – with cloud-based …

… Bio today announced a license agreement granting Biogen exclusive … Biogen is a leading biotechnology company that pioneers innovative … potential of Biogen’s license agreement with Vanqua Bio; … -term success in developing, licensing, or acquiring other product …

… collaboration agreement with Shanghai Henlius Biotech, Inc., to develop innovative … of the agreement, Forlong Biotechnology will fuse a monoclonal antibody … development milestone, further licensing fee payments. Forlong Biotechnology has developed a …

… for a licensing deal in China’s biotech sector. Just … this pipeline from Chinese biotech company Biotheus through the … s biotech sector, observes that the surge in outbound licensing … and the transaction between BeiHai Biotech and Zydus. “These transactions …

… portfolio of innovative assets and biotech solutions for the treatment of … of development, today announced its licensee, Unbuzzd Wellness Inc. ("Unbuzzd … portfolio of innovative assets and biotech solutions for the treatment of …

… needed to streamline and modernise licensing systems. Aligning these with international … a requirement for screening in licensing, procurement and oversight mechanisms. … governance to remain agile as biotech capabilities advance. Adopting harmonised, …